Evidence map›Paper›PMID 25723153›Full record

ArticlePloS one2015

Two types of functionally distinct fiber containing structural protein complexes are produced during infection of adenovirus serotype 5.

Bo Zhang, Yuhua Yan, Jie Jin, Hongyu Lin, Zongyi Li, Xiaoyan Zhang, Jin Liu, Chao Xi, Andre Lieber, Xiaolong Fan and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Bo ZhangBeijing Key Laboratory of Gene Resources and Molecular Development, College of Life Science, Beijing Normal University, Beijing, China.
Yuhua YanBeijing Key Laboratory of Gene Resources and Molecular Development, College of Life Science, Beijing Normal University, Beijing, China.
Jie JinBeijing Key Laboratory of Gene Resources and Molecular Development, College of Life Science, Beijing Normal University, Beijing, China.
Hongyu LinBeijing Key Laboratory of Gene Resources and Molecular Development, College of Life Science, Beijing Normal University, Beijing, China.
Zongyi LiDivision of Medical Genetics, University of Washington, Seattle, Washington, United States of America.
Xiaoyan ZhangBeijing Key Laboratory of Gene Resources and Molecular Development, College of Life Science, Beijing Normal University, Beijing, China.
Jin LiuBeijing Key Laboratory of Gene Resources and Molecular Development, College of Life Science, Beijing Normal University, Beijing, China.
Chao XiBeijing Key Laboratory of Gene Resources and Molecular Development, College of Life Science, Beijing Normal University, Beijing, China.
Andre LieberDivision of Medical Genetics, University of Washington, Seattle, Washington, United States of America.
Xiaolong FanBeijing Key Laboratory of Gene Resources and Molecular Development, College of Life Science, Beijing Normal University, Beijing, China.
Liang RanBeijing Key Laboratory of Gene Resources and Molecular Development, College of Life Science, Beijing Normal University, Beijing, China.
Beijing Normal University · CNUniversity of Washington Medical Center · US

Funding

ONCOLYTIC ADENOVIRUSES FOR CERVICAL CANCER GENE THERAPYR01CA080192 · NCI · UNIVERSITY OF WASHINGTON · PI LIEBER, ANDRE MICHAEL · 1999 to 2009
$2.0M
NCI NIH HHS R01 CA080192PHS HHS R01 HLA078836
6 · The paper itself

Abstract

Adenoviruses are common pathogens. The localization of their receptors coxsackievirus and adenovirus receptor, and desmoglein-2 in cell-cell junction complexes between polarized epithelial cells represents a major challenge for adenovirus infection from the apical surface. Structural proteins including hexon, penton base and fiber are excessively produced in serotype 5 adenovirus (Ad5)-infected cells. We have characterized the composition of structural protein complexes released from Ad5 infected cells and their capacity in remodeling cell-cell junction complexes. Using T84 cells as a model for polarized epithelium, we have studied the effect of Ad5 structural protein complexes in remodeling cell-cell junctions in polarized epithelium. The initial Ad5 infection in T84 cell culture was inefficient. However, progressive distortion of cell-cell junction in association with fiber release was evident during progression of Ad5 infection. Incubation of T84 cell cultures with virion-free supernatant from Ad5 infected culture resulted in distortion of cell-cell junctions and decreased infectivity of Ad5-GFP vector. We used gel filtration chromatography to fractionate fiber containing virion-free supernatant from Ad5 infected culture supernatant. Fiber containing fractions were further characterized for their capacity to inhibit the infection of Ad5-GFP vector, their composition in adenovirus structural proteins using western blot and LC-MS/MS and their capacity in remolding cell-cell junctions. Fiber molecules in complexes containing penton base and hexon, or mainly hexon were identified. Only the fiber complexes with relatively high content of penton base, but not the fiber-hexon complexes with low penton base, were able to penetrate into T84 cells and cause distortion of cell-cell junctions. Our findings suggest that these two types of fiber complexes may play different roles in adenoviral infection.

Indexed as

Virus ReplicationAdenoviruses, HumanAdenovirus Infections, HumanCapsid ProteinsCells, CulturedCoxsackie and Adenovirus Receptor-Like Membrane ProteinDesmoglein 2Epithelial CellsGene ExpressionGenes, ReporterGenetic VectorsHumansIntercellular JunctionsMultiprotein ComplexesVirionCapsid ProteinsCoxsackie and Adenovirus Receptor-Like Membrane ProteinDesmoglein 2hexon capsid protein, AdenovirusMultiprotein Complexespenton protein, adenovirus

Identifiers

PMID25723153
PMCPMC4344211
OpenAlexW2034991313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.